75 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Invacare Corporation IVC shares climbed 33.6% to $10.54 after the company reported upbeat Q3 earnings.
• Collegium Pharmaceutical, Inc COLL gained 30.2% to $17.84 after the company reported better-than-expected Q3 EPS.
• NexTier Oilfield Solutions Inc. NEX shares climbed 28.3% to $5.22 following Q3 results.
• DexCom, Inc. DXCM shares rose 27.5% to $195.18 after the company posted upbeat Q3 results and raised FY2019 sales guidance.
• Nevro Corp. NVRO gained 26% to $107.33 after the company posted upbeat Q3 results and raised FY19 sales guidance.
• Vista Outdoor Inc. VSTO shares gained 25% to $8.62 after reporting Q2 results.
• Sally Beauty Holdings, Inc. SBH rose 22.2% to $20.34 after the company reported better-than-expected Q4 EPS and sales results.
• ANGI Homeservices Inc. ANGI climbed 20% to $7.75 after the company reported better-than-expected Q3 EPS and sales results.
• Quanterix Corporation QTRX gained 19.8% to $23.11 following Q3 results.
• CommScope Holding Company, Inc. COMM climbed 19% to $13.98 after the company reported better-than-expected Q3 EPS results.
• Coherus BioSciences, Inc. CHRS jumped 17.9% to $19.40. The company on Wednesday reported Q3 results and acquired the rights to commercialize Bioeq's biosimilar candidate Lucentis.
• DXP Enterprises, Inc. DXPE gained 17.8% to $42.46 after reporting upbeat Q3 results.
• Tutor Perini Corporation TPC climbed 17.8% to $18.50 following Q3 results.
• Livongo Health, Inc. LVGO shares rose 17.5% to $24.90 after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 sales guidance and issued Q4 sales guidance above analyst estimates.
• Clovis Oncology, Inc. CLVS gained 17% to $4.19 following Q3 results. The company reported better-than-expected EPS and sales and a 42% year-over-year drop in cash burn.
• Triple-S Management Corporation GTS jumped 17% to $18.30 after the company posted upbeat Q3 results and raised FY19 EPS guidance.
• Triumph Group, Inc. TGI gained 16.8% to $26.59 following Q2 results.
• National Vision Holdings, Inc. EYE rose 16.2% to $28.86 following Q3 results.
• GoDaddy Inc. GDDY gained 15.8% to $72.76 after the company reported better-than-expected Q3 EPS results.
• Marchex, Inc. MCHX climbed 15.4% to $3.75 following Q3 results.
• TimkenSteel Corporation TMST gained 15.2% to $6.99 following Q3 results.
• SeaWorld Entertainment, Inc. SEAS gained 15% to $29.67 after the company posted Q3 results and named Sergio Rivera as CEO.
• AxoGen, Inc. AXGN gained 15% to $15.27 following strong Q3 results.
• iQIYI, Inc. IQ rose 14.4% to $19.97 after the company reported better-than-expected Q3 EPS results.
• Vanda Pharmaceuticals Inc. VNDA climbed 14.2% to $15.00 after reporting upbeat quarterly results.
• Enlivex Therapeutics Ltd. ENLV rose 13.7% to $7.52.
• Hepion Pharmaceuticals, Inc. HEPA gained 13.5% to $3.3477. Hepion Pharmaceuticals' CRV431 reduced liver fibrosis in a western diet model of NASH.
• Maverix Metals Inc. MMX climbed 13.4% to $4.40.
• ZAGG Inc ZAGG gained 12% to $8.20 following strong quarterly sales.
• Baidu, Inc. BIDU rose 11.8% to $119.97 after the company reported better-than-expected Q3 EPS and sales results.
• ARCA biopharma, Inc. ABIO gained 11.7% to $5.82 following Q3 results.
• Arvinas, Inc. ARVN climbed 11.6% to $25.00. Arvinas priced 4.5 million share public offering of common stock at $22 per share.
• SailPoint Technologies Holdings, Inc. SAIL rose 11.1% to $22.37 after the company reported better-than-expected Q3 EPS and sales results.
• Genco Shipping & Trading Limited GNK climbed 11.1% to $11.00 following Q3 results.
• Earthstone Energy, Inc. ESTE gained 10.8% to $5.02 following upbeat Q3 results.
• Adient plc ADNT gained 8.9% to $25.59 after reporting upbeat quarterly earnings.
• QUALCOMM Incorporated QCOM rose 8.8% to $92.07 after the company reported better-than-expected Q4 EPS and sales results.
• InflaRx N.V. IFRX rose 8.1% to $2.8001 after reporting positive results from the open label extension part of the SHINE study for IFX-1 in hidradenitis suppurativa.
• ArcelorMittal MT rose 7.6% to $17.02 after the company reported Q3 results.
• TherapeuticsMD, Inc. TXMD rose 6.1% to $2.78 following Q3 results.

Check out these big penny stock gainers and losers

Losers

• Party City Holdco Inc. PRTY shares tumbled 59.7% to $2.46 after the company reported worse-than-expected Q3 EPS and sales results. The company also cut its FY19 EPS and sales guidance below analyst estimates.
• Top Ships Inc. TOPS dropped 55.5% to $1.2650. TOP Ships priced its 4.2 million share common stock offering at $2 per share.
• ObsEva SA OBSV dropped 50.7% to $3.9655. Obseva said the results from the Phase 2 European confirmatory study of nolasiban in women undergoing embryo transfer following in-vitro fertilization did not meet the primary endpoint of an increase in ongoing pregnancy rate at 10 weeks.
• Allena Pharmaceuticals, Inc. ALNA shares dipped 50.1% to $2.9219 after the company disclosed that its Phase 3 trial of URIROX-1 met its primary endpoint.
• Liberty TripAdvisor Holdings, Inc. LTRPA shares tumbled 27.4% to $7.17.
• Sensus Healthcare, Inc. SRTS dropped 27% to $4.15 following downbeat Q3 results.
• EyePoint Pharmaceuticals, Inc. EYPT dipped 25.8% to $1.7150 following downbeat Q1 results.
• Rosetta Stone Inc. RST dropped 24.3% to $15.39 after reporting weak Q3 sales.
• Expedia Group, Inc. EXPE fell 24.2% to $102.58 after the company reported worse-than-expected Q3 EPS and sales results.
• TPI Composites, Inc. TPIC dipped 23.6% to $16.52 following Q3 results.
• Arcadia Biosciences, Inc. RKDA fell 23.4% to $4.4201 after the company reported weaker-than-expected earnings for its third quarter.
• Melinta Therapeutics, Inc. MLNT dropped 23.3% to $2.1551.
• Fossil Group, Inc. FOSL shares fell 22% to $9.80 after the company reported Q3 EPS of $(0.51) compared to the $0.09 estimate and worse-than-expected sales results.
• Tonix Pharmaceuticals Holding Corp. TNXP dropped 21% to $2.58.
• Lannett Company, Inc. LCI fell 20.5% to $9.94 after the company reported Q1 EPS and sales results down fom last year.
• TripAdvisor, Inc. TRIP dipped 19.8% to $32.72 after the company reported worse-than-expected Q3 EPS and sales results.
• Aerie Pharmaceuticals, Inc. AERI dipped 19.7% to $19.13 after the company reported worse-than-expected Q3 EPS results.
• Cytokinetics, Incorporated CYTK dropped 18.3% to $8.85.
• MoSys, Inc. MOSY fell 17.4% to $1.8506 following Q3 results.
• Upwork Inc UPWK fell 17% to $12.51 after the company narrowed the high end of FY19 sales guidance.
• Camber Energy, Inc. CEI dipped 15.8% to $1.71.
• Castor Maritime Inc. CTRM dropped 14.1% to $2.81.
• U.S. Physical Therapy, Inc. USPH fell 14% to $126.37 following Q3 results.
• Kinross Gold Corporation KGC fell 13.5% to $4.16 after the company reported worse-than-expected Q3 sales results.
• Core-Mark Holding Company, Inc. CORE tumbled 13.5% to $28.54 after the company posted downbeat Q3 sales and lowered FY19 sales guidance.
• Meridian Bioscience, Inc. VIVO dropped 13.4% to $8.53 after the company issued weak FY20 earnings forecast.
• Bandwidth Inc. BAND dipped 12.6% to $48.48 following Q3 results.
• Agile Therapeutics, Inc. AGRX fell 12.6% to $2.1601.
• Globus Maritime Limited GLBS dropped 11.7% to $2.0301.
• Eldorado Gold Corporation EGO fell 11% to $7.93.
• TreeHouse Foods, Inc. THS dipped 10.6% to $49.35 after the company reported downbeat Q3 results.
• RealPage, Inc. RP fell 10.1% to $53.72 after the company reported Q3 results and to announced plans to acquire Buildium for $580 million in cash.
• Inseego Corp INSG shares fell 10% to $4.7834 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 sales guidance below estimates.
• Roku, Inc. ROKU fell 9.7% to $127.37 despite the company reporting better-than-expected Q3 EPS and sales results.
• Hecla Mining Company HL fell 9.3% to $2.15 after the company reported Q3 results.